CUSIP: 65344D109
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,437,643
-
Share change
-
-1,310,316
-
Total reported value
-
$1,251,851
-
Price per share
-
$0.28
-
Number of holders
-
30
-
Value change
-
-$452,426
-
Number of buys
-
8
-
Number of sells
-
9
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 65344D109:
Institutional Holders of NEXIMMUNE INC - COM (NEXI) as of Q2 2023
As of 30 Jun 2023,
NEXIMMUNE INC - COM (NEXI) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,437,643 shares.
The largest 10 holders included
Slate Path Capital LP, ADAGE CAPITAL PARTNERS GP, L.L.C., ALLEN OPERATIONS LLC, EPIQ Capital Group, LLC, RAYMOND JAMES & ASSOCIATES, PNC Financial Services Group, Inc., FIRST MANHATTAN CO. LLC., M28 Capital Management LP, Caprock Group, LLC, and VANGUARD GROUP INC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.